BK Virus Clinical Trials

1 recruiting

BK Virus Trials at a Glance

7 actively recruiting trials for bk virus are listed on ClinicalTrialsFinder across 5 cities in 4 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in Houston, Bangkok, and New York. Lead sponsors running bk virus studies include M.D. Anderson Cancer Center, Columbia University, and King Chulalongkorn Memorial Hospital.

Browse bk virus trials by phase

Treatments under study

About BK Virus Clinical Trials

Looking for clinical trials for BK Virus? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new BK Virus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about BK Virus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting

Immune Registry for BK in Kidney Transplant Recipients

Kidney Transplant; ComplicationsBK Virus Infection
Virginia Commonwealth University60 enrolled1 locationNCT06538961
Recruiting
Not Applicable

The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

BK Virus InfectionKidney Transplant Infection
King Chulalongkorn Memorial Hospital50 enrolled1 locationNCT04542733
Recruiting
Phase 2

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Merkel Cell CarcinomaMalignant NeoplasmAcquired Immunodeficiency Syndrome+5 more
M.D. Anderson Cancer Center100 enrolled1 locationNCT02479698
Recruiting

New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies

BK Virus Infection
University Hospital, Strasbourg, France100 enrolled1 locationNCT05264259
Recruiting
Phase 1

R-MVST Cells for Treatment of Viral Infections

Epstein-Barr Virus InfectionsCytomegalovirus InfectionsBK Virus Infection+1 more
Columbia University36 enrolled1 locationNCT05183490
Recruiting
Phase 1

Coadministration of Malignancy and Infection specific T cells after allogeneic stem cell Transplant for Acute Leukaemia with CD34+ selected stem cells

AspergillusInfluenza virusBK Virus+2 more
Western Sydney Local Health District, Westmead Hospital20 enrolled1 locationACTRN12618001090202